GTR Home > Laboratories > Molecular Diagnostics Laboratory

Molecular Diagnostics Laboratory

GTR Lab ID: 246260, Last updated:2016-03-27
Annual Review past due read more

Personnel

  • Director: Suzanne Kamel-Reid, PhD, FACMG, Lab Director
  • Director: Tracy Stockley, PhD, FACMG, Lab Associate Director
  • Director: Cuihong Wei, PhD, FACMG, Lab Associate Director

Conditions and tests

  • Acute lymphoid leukemia1 test
  • Acute myeloid leukemia3 tests
  • Amyloidogenic transthyretin amyloidosis2 tests
  • Bannayan-Riley-Ruvalcaba syndrome1 test
  • Cellular mosaicism1 test
  • Chronic myelogenous leukemia2 tests
  • Colorectal cancer2 tests
  • Cowden syndrome 11 test
  • Cutaneous malignant melanoma 21 test
  • Cutaneous malignant melanoma 31 test
  • Cutaneous malignant melanoma 51 test
  • Cutaneous malignant melanoma 81 test
  • Endometrial carcinoma1 test
  • Erythrocytosis, familial, 21 test
  • Familial visceral amyloidosis, Ostertag type2 tests
  • Focal cortical dysplasia type II1 test
  • Hairy cell leukemia1 test
  • Hemochromatosis type 11 test
  • Hereditary breast and ovarian cancer syndrome1 test
  • Hereditary nonpolyposis colorectal cancer type 41 test
  • Hereditary nonpolyposis colorectal cancer type 51 test
  • Hereditary nonpolyposis colorectal cancer type 81 test
  • Lymphangiomyomatosis1 test
  • Lymphoproliferative disorder1 test
  • Lynch syndrome I1 test
  • Lynch syndrome II1 test
  • Macrocephaly/autism syndrome1 test
  • Malignant hyperthermia susceptibility type 51 test
  • Malignant hyperthermia, susceptibility to, 11 test
  • Malignant melanoma1 test
  • Melanoma astrocytoma syndrome1 test
  • Melanoma, cutaneous malignant, susceptibility to, 101 test
  • Melanoma-pancreatic cancer syndrome1 test
  • Meretoja syndrome2 tests
  • Muir-TorrĂ© syndrome1 test
  • Multiple cutaneous leiomyomas2 tests
  • Multiple fibrofolliculomas2 tests
  • Nasopharyngeal carcinoma1 test
  • Papillary thyroid carcinoma1 test
  • Paraganglioma and gastric stromal sarcoma2 tests
  • Paragangliomas 32 tests
  • Paragangliomas 52 tests
  • Pheochromocytoma1 test
  • Renal cell carcinoma, papillary, 12 tests
  • Solid tumor1 test
  • Tuberous sclerosis 11 test
  • Tuberous sclerosis 21 test
  • Tumor susceptibility linked to germline BAP1 mutations1 test
  • Turcot syndrome1 test
  • VACTERL association with hydrocephalus1 test
  • Von Hippel-Lindau syndrome1 test

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously
  • DNA Banking
  • Identity Testing
  • Mutation Confirmation
  • RNA Banking
  • Result interpretation

List of certifications/licenses

Certifications

  • CLIAHelp, Number: 99D1106115, Expiration date: 2017-04-20
  • CAP, Number: 7175217, Expiration date: 2015-06-30
  • Ontario Laboratory Accreditation (OLA), Number: OLA 4204, Expiration date: 2017-04-26

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center